The COVID-19 pandemic has caused an influx of patients in hospitals and acute care facilities and it’s only expected to get worse. As a result, any procedure or service that is deemed “non-essential” is being shut down immediately. Many hospitals have already categorized wound care as “non-essential.”
The Alliance of Wound Care Stakeholders worry that shutting down wound care centers will result in unintended, negative consequences and cause a greater influx of patients in emergency care. If nonhealing wounds are not treated or managed, the results could be drastic, such as infections, sepsis, amputations or even fatalities. Such results are why wound care is so essential.
People with nonhealing wounds typically suffer from other, underlying conditions as well, such as diabetes, hypertension, venous insufficiency, peripheral artery disease and/or chronic kidney disease. These patients are considered high-risk if they are affected by COVID-19, however, they’re also considered high-risk for amputations, or even death, if their wound care immediately stops.
PREVENTOGEN is an advanced wound care polymer that will provide patients an immediate benefit of killing pathogens on contact, sealing and protecting the wound with a flexible, biodegradable barrier that is durable, transparent, water-resistant and promotes faster healing.